Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARENTIDE cream for histamine-induced itch in healthy volunteers
2022-001374-60Phase 2Completed
- Sponsor
- BCN Peptides
- Start
- May 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of parentide in pruritus and urticaria (3 arms), sponsored by BCN Peptides. Primary endpoint: Visual Analog Scale score for itch. Started May 2022; status: completed.
02
Drugs
parentide
03
Conditions
pruritusurticaria
Beyond the preview
Go deeper on 2022-001374-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-001374-60.